This monthās tariff agreements with the United Kingdom and China might end up being the first deal of its kind, and the last. On Friday, President Trump reiterated that the administration could not possibly strike deals with every country, and that tariff announcements would be made over the next two to three weeks.
While CPA recognizes certain positive elements of the deal ā including a historic pivot towards prioritizing tariff revenue as well as industrial protection ā it remains concerned about dangerous precedents being set by sacrificing domestic production while pursuing foreign market access.
By maintaining the 10% baseline tariff and capping UK auto imports at 100,000 vehicles per year before higher tariffs apply, the administration is demonstrating that trade policy can and should be used to protect and rebuild domestic industry.
The U.S. must not sacrifice the chance to rebuild industrial capacity in exchange for another empty trade promise to import more American goods, as if these promises will actually materialize.
Importers continued to front-run the April āLiberation Dayā tariffs in March, sending the overall trade deficit up 14% over February numbers to $140.5 billion for the month, according to the Bureau of Economic Analysis (BEA) on Tuesday.
President Trump’s Executive Order is a bold, necessary move to rebuild Americaās pharmaceutical industry and protect our citizens.
Democrats on the Economic Growth, Energy Policy, and Regulatory Affairs Subcommitteeāof the House Committee on Oversight and Government Reformāare united against tariffs.
President Trump’s action to close the de minimis loophole for China is a monumental victory for American workers, manufacturers, and national security.
Foreign imports primarily from Cambodia, Malaysia, Mexico, Thailand, and Vietnamāthat are heavily subsidized by Chinaāare destroying American cabinet jobs.
The American people, Congress, and the President have spoken. Now itās Wall Streetās turn to decide.
